| Maryann Salib, DO | |
|
861 E Allegheny Ave, Philadelphia, PA 19134-2401 | |
| (215) 831-1100 | |
| Not Available |
| Full Name | Maryann Salib |
|---|---|
| Gender | Female |
| Speciality | Preventive Medicine - Public Health & General Preventive Medicine |
| Location | 861 E Allegheny Ave, Philadelphia, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275978033 | NPI | - | NPPES |
| 1035329750003 | Medicaid | PA | |
| 1035329750001 | Medicaid | PA | |
| 1035329750002 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083P0901X | Preventive Medicine - Public Health & General Preventive Medicine | OS019463 (Pennsylvania) | Primary |
| Entity Name | Esperanza Health Center, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255726659 PECOS PAC ID: 6103815071 Enrollment ID: O20040507000367 |
News Archive
Eisai Co., Ltd. and Merck & Co., Inc., Kenilworth N.J., U.S.A., known as MSD outside of the United States and Canada, announced that the China National Medical Products Administration approved the kinase inhibitor LENVIMA (lenvatinib) as a single agent for the treatment of patients with unresectable hepatocellular carcinoma who have not received prior systemic therapy.
The planned closure of St. Vincent's Hospital in New York City raises concerns as other hospitals plan to accommodate its patients.
Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS) announced today that dosing has begun in a Phase II trial of ANA598 in patients chronically infected with hepatitis C virus (HCV). The study will evaluate ANA598 over 12 weeks, taken in combination with pegylated interferon-alpha and ribavirin, in treatment naive HCV patients. ANA598 is an investigational, oral, non-nucleoside polymerase inhibitor.
For people whose hands shake uncontrollably due to a medical condition, just eating can be a frustrating and embarrassing ordeal - enough to keep them from sharing a meal with others.
A digital mammography system developed based on concepts originally tested at Massachusetts General Hospital (MGH) has been approved by the U.S. Food and Drug Administration.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Maryann Salib, DO 4417 N 6th St, Philadelphia, PA 19140-2319 Ph: (215) 302-3600 | Maryann Salib, DO 861 E Allegheny Ave, Philadelphia, PA 19134-2401 Ph: (215) 831-1100 |
News Archive
Eisai Co., Ltd. and Merck & Co., Inc., Kenilworth N.J., U.S.A., known as MSD outside of the United States and Canada, announced that the China National Medical Products Administration approved the kinase inhibitor LENVIMA (lenvatinib) as a single agent for the treatment of patients with unresectable hepatocellular carcinoma who have not received prior systemic therapy.
The planned closure of St. Vincent's Hospital in New York City raises concerns as other hospitals plan to accommodate its patients.
Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS) announced today that dosing has begun in a Phase II trial of ANA598 in patients chronically infected with hepatitis C virus (HCV). The study will evaluate ANA598 over 12 weeks, taken in combination with pegylated interferon-alpha and ribavirin, in treatment naive HCV patients. ANA598 is an investigational, oral, non-nucleoside polymerase inhibitor.
For people whose hands shake uncontrollably due to a medical condition, just eating can be a frustrating and embarrassing ordeal - enough to keep them from sharing a meal with others.
A digital mammography system developed based on concepts originally tested at Massachusetts General Hospital (MGH) has been approved by the U.S. Food and Drug Administration.
› Verified 8 days ago
Hannah Coleen Mclane, MD Preventive Medicine Medicare: Medicare Enrolled Practice Location: 3400 Spruce St, Philadelphia, PA 19104 Phone: 215-662-4000 | |
Dr. Rebecca M Steinberg, M.D., MPH, MS Preventive Medicine Medicare: Medicare Enrolled Practice Location: 4898 S Broad St Bldg 615, Philadelphia, PA 19112 Phone: 215-897-8147 | |
Dr. Evelyn Kemi Balogun, MD,MPH Preventive Medicine Medicare: Medicare Enrolled Practice Location: 3401 N Broad St, Philadelphia, PA 19140 Phone: 215-707-8150 Fax: 215-707-5751 | |
Kenneth Marsaglia Ii, Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 8414 Bridle Road, Philadelphia, PA 19111 Phone: 267-357-3406 | |
Dr. Ron Joines, MD, MPH Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 200 N 16th St, Mail Code Fp 1605, Philadelphia, PA 19102 Phone: 215-751-6275 Fax: 215-751-5252 | |
Dr. Tricia M Loehrig, D.O. Preventive Medicine Medicare: Accepting Medicare Assignments Practice Location: 2981 Grant Ave, Philadelphia, PA 19114 Phone: 215-632-4550 Fax: 215-632-7865 | |
Dr. Roy Alvin Stahlman, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 3751 Island Ave, Suite 5, Philadelphia, PA 19153 Phone: 215-492-2400 Fax: 215-492-1245 |